EB

Edward Andrew Boyd

CU Curis: 13 patents #9 of 139Top 7%
OL Oxagen Limited: 6 patents #3 of 17Top 20%
Hoffmann-La Roche: 4 patents #813 of 3,238Top 30%
Pfizer: 4 patents #1,262 of 5,153Top 25%
Genentech: 3 patents #890 of 2,392Top 40%
BL British Technology Group Limited: 3 patents #32 of 501Top 7%
AL Asterand Uk Limited: 3 patents #12 of 17Top 75%
Merck: 1 patents #5,419 of 9,382Top 60%
EA Evotec Oai Ag: 1 patents #10 of 39Top 30%
Overall (All Time): #86,944 of 4,157,543Top 3%
38
Patents All Time

Issued Patents All Time

Showing 25 most recent of 38 patents

Patent #TitleCo-InventorsDate
8852937 Small organic molecule regulators of cell proliferation Anthony David Baxter, Maria Frank-Kamenetsky, Oivin Guicherit, Jeffery Porter, Stephen Price +2 more 2014-10-07
8815895 Mediators of hedgehog signaling pathways, compositions and uses related hereto Oivin Guicherit, Shirley Ann Brunton, Stephen Price, John Harry Alexander Stibbard, Colin H. MacKinnon 2014-08-26
8772275 Mediators of hedgehog signaling pathways, compositions and uses related thereto Lee L. Rubin, Oivin Guicherit, Stephen Price 2014-07-08
8354397 Mediators of hedgehog signaling pathways, compositions and uses related thereto Lee L. Rubin, Oivin Guicherit, Stephen Price 2013-01-15
8314257 Treatment of CRTH2-mediated diseases and conditions David Middlemiss, Mark Richard Ashton, Frederick Arthur Brookfield, Michael George Hunter, Mark Whittaker +2 more 2012-11-20
8198314 Treatment of CRTH2-mediated diseases and conditions David Middlemiss, Mark Richard Ashton, Frederick Arthur Brookfield, Michael George Hunter, Mark Whittaker +2 more 2012-06-12
8198298 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors Barbara Salom, Matteo D'Anello, Maria Gabriella Brasca, Patrizia Giordano, Katia Martina +4 more 2012-06-12
8168653 Mediators of hedgehog signaling pathways, compositions and uses related thereto Oivin Guicherit, Shirley Ann Brunton, Stephen Price, John Harry Alexander Stibbard, Colin H. MacKinnon 2012-05-01
8163936 Treatment of CRTH2-mediated diseases and conditions David Middlemiss, Mark Richard Ashton, Frederick Arthur Brookfield, Michael George Hunter, Mark Whittaker +2 more 2012-04-24
8163931 Treatment of CRTH2-mediated diseases and conditions David Middlemiss, Mark Richard Ashton, Frederick Arthur Brookfield, Michael George Hunter, Mark Whittaker +2 more 2012-04-24
8129425 Small organic molecule regulators of cell proliferation Anthony David Baxter, Maria Frank-Kamenetsky, Oivin Guicherit, Jeffery Porter, Stephen Price +2 more 2012-03-06
8106069 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them Barbara Salom, Matteo D'Anello, Maria Gabriella Brasca, Patrizia Giordano, Katia Martina +4 more 2012-01-31
8080567 EP2 receptor agonists Alexander W. Oxford, Richard Jon Davis, Robert Alexander Coleman, Kenneth Lyle Clark, David Edward Clark +7 more 2011-12-20
8044088 1-acetic acid-indole derivatives with PGD2 antagonist activity Richard Edward Armer, Philip Andrew Hay 2011-10-25
7888508 Pyrrolo[2,3-B]pyridine derivatives active as kinase inhibitors Barbara Salom, Matteo D'Anello, Maria Gabriella Brasca, Patrizia Giordano, Katia Martina +4 more 2011-02-15
7816369 Mediators of hedgehog signaling pathways, compositions and uses related thereto Oivin Guicherit, Shirley Ann Brunton, Stephen Price, John Harry Alexander Stibbard, Colin H. MacKinnon 2010-10-19
7803841 EP2 receptor agonists Alexander W. Oxford, Richard Jon Davis, Robert Alexander Coleman, Kenneth Lyle Clark, David Edward Clark +7 more 2010-09-28
7776878 Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents Frederick Arthur Brookfield, Jonathan Gridley, Konrad Honold, Raymond Lau, Stefan Scheiblich 2010-08-17
7728140 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them Barbara Salom, Matteo D'Anello, Maria Gabriella Brasca, Patrizia Giordano, Katia Martina +4 more 2010-06-01
7662839 EP2 receptor agonists Alexander W. Oxford, Richard Jon Davis, Robert Alexander Coleman, Kenneth Lyle Clark, David Edward Clark +7 more 2010-02-16
7582672 Compounds for the treatment of CRTH2-mediated diseases and conditions David Middlemiss, Mark Richard Ashton, Frederick Arthur Brookfield, Eric Roy Pettipher, Michael George Hunter +2 more 2009-09-01
7414067 Ophthalmic compositions for treating ocular hypertension Michael H. Fisher, Maria L. Garcia, Gregory J. Kaczorowski, Peter T. Meinke, William H. Parsons +2 more 2008-08-19
7326732 EP2 receptor agonists Alexander W. Oxford, Richard Jon Davis, Robert Alexander Coleman, Kenneth Lyle Clark, David Edward Clark +7 more 2008-02-05
7300929 Mediators of hedgehog signaling pathways, compositions and uses related thereto Anthony David Baxter, Oivin Guicherit, Stephen Price, Lee L. Rubin 2007-11-27
7259273 Compositions containing lysophosphotidic acids which inhabit apoptosis and uses thereof John G. Goddard, Donald H. Picker, Samuil R. Umansky, Steven Price, Jac Wijkmans +1 more 2007-08-21